GW Pharmaceuticals Plc ADS (GWPH)

[FSUBCSchamps]

Let's not call them consumers, they are patients! The consumer (British Healthcare System) has decided that their patients don't need the drug.

In the US we still have freedom to switch insurance to a different company whose prescription formulary is different- at least for now

This is essentially insignificant for shareholders as the rights to Sativex has been essentially sold to Bayer. But theoretically if they cut prices it would greatly affect Research and Development where almost all of GWPH revenue goes.

That would have affected children hoping to get Epidiolex and the large pipeline of potential uses for Sativex and Epidiolex. You can't possibly think that would have been good for patients-- British or anywhere. Luckily GWPH has had its eyes on US and British revenue was never the goal or depended on.